FDA Approves New Drug for Schizophrenia, Bipolar Disorder

Share this content:
FDA Approves New Drug for Schizophrenia, Bipolar Disorder
FDA Approves New Drug for Schizophrenia, Bipolar Disorder

FRIDAY, Sept. 18, 2015 (HealthDay News) -- A new antipsychotic drug to treat schizophrenia and bipolar disorder in adults has been approved by the U.S. Food and Drug Administration. The drug, Vraylar (cariprazine), is a capsule taken once a day.

The drug's effectiveness in treating schizophrenia was tested in 1,754 patients in three six-week clinical trials. It was shown to reduce schizophrenia symptoms compared to a placebo. The most commonly reported side effects in the schizophrenia trials were tremor, slurred speech, and involuntary muscle movements.

In three three-week trials involving 1,037 bipolar patients, Vraylar reduced disorder symptoms, the FDA said. The most common drug-related side effects in the bipolar disorder trials included tremor, slurred speech, akathisia, dyspepsia, vomiting, drowsiness, and restlessness.

All FDA-approved drugs for schizophrenia and bipolar disorder must carry a black-box warning indicating an increased risk of death if these drugs are used by older people with dementia-related psychosis, the agency noted.

The drug's maker, Forest Labs, and distributor, Actavis Pharma, are based in New Jersey.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Pharmacists Should Counsel Patients Fasting for Ramadan

Pharmacists Should Counsel Patients Fasting for Ramadan

Pharmacists can suggest adjustments for meds taken several times per day, those affected by food intake

AUA: Many Have Unused Opioids After Urologic Procedures

AUA: Many Have Unused Opioids After Urologic Procedures

Patients use just over half of initial prescription; highest percentage of unused meds for cystectomy

Over Half of Young Adult Smoke Volume Exposure From Hookahs

Over Half of Young Adult Smoke Volume Exposure ...

Toxicant exposure to tar, carbon monoxide, nicotine lower, but still substantial, compared to cigarettes

is free, fast, and customized just for you!

Already a member?

Sign In Now »